Rettew et al. have previously reported that genetic upregulation of EphB2, FGFR2, and RET, which encode RTKs, increases the metastatic potential of tumor cells by enhancing cell proliferation, motility, invasion, and tumorigenicity [31, 32]. This evidence concerns the gene EPHB2 and neoplasm.